APMA is aware of the ongoing shortages of lidocaine and the significant impact that these shortages are having on members’ practices. While the causes of the shortage and potential solutions are complex and multifactorial, APMA has compiled the following resources for members who are facing lidocaine shortages.
These resources provide information on drug supply chain and shortage issues. The last listed link, ASHP Shortage List, is a searchable database. This database provides anticipated release dates for products. Note that the release date is when the product is available to distributors. Where your practice falls within the distributor's allocation process will determine when you receive product.
In terms of immediate options, APMA recommends the following:
APMA will continue to monitor this concern and investigate solutions with policymakers and other impacted stakeholders.